Intended for healthcare professionals

Editorials

SGLT2 inhibitors and kidney outcomes in the real world

BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1584 (Published 29 April 2020) Cite this as: BMJ 2020;369:m1584

Linked Research

Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events

Linked Analysis

Communicating emerging risks of SGLT2 inhibitors